For example, ERCC1 expression levels have an inverse correlation with either response to platinum-based adjuvant chemotherapy or survival in patients with ovarian cancer, colorectal cancer, and non-small cell lung cancer (NSCLC) [38–40]. This evidence concerns the gene ERCC1 and colorectal cancer.